Stroke management.
Gubitz
Gord
G
Division of Neurology, Dalhousie University, Halifax, Canada.
Sandercock
Peter
P
D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use; D002543:Cerebral Hemorrhage / Q000209:etiology / Q000401:mortality / Q000628:therapy; D002544:Cerebral Infarction / Q000209:etiology / Q000401:mortality / Q000628:therapy; D003131:Combined Modality Therapy; D006801:Humans; D018696:Neuroprotective Agents / Q000009:adverse effects / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D020521:Stroke / Q000209:etiology / Q000401:mortality / Q000628:therapy*; D015996:Survival Rate; D015912:Thrombolytic Therapy
D018696:Neuroprotective Agents; D001241:Aspirin